Here are eight things for spinal surgeons to know for Dec. 22, 2016.
4 neurosurgery market drivers through 2020
Technavio analysts identified the major drivers of growth in the neurosurgery market, which will likely grow at a compound annual growth rate of 9 percent between 2016 and 2020. Here are the top four market drivers: more neurological disorder cases; technological advancements; demand for minimally invasive surgeries; and awareness of innovative products.
Orthopedic surgeons donate $928k to Dr. Tom Price over 12-year period
Tom Price, MD, President-elect Donald Trump's pick for HHS secretary, has received a large portion of funding from medical specialists. From 2004 to 2016, orthopedic surgeons provided Dr. Price $926,639. Anesthesiologists are the next biggest contributors, donating $256,888 during the aforementioned time frame.
Dr. Said Osman to open Advanced Spine Endoscopy and Pain Institute in January
Said G. Osman, MD, is opening Advanced Spine Endoscopy and Pain Institute in Frederick, Md., on Jan. 16, 2017. Because of growing demand for minimally invasive endoscopic spine surgeries from patients in the Frederick, Washington, Carroll, Howard and Montgomery Counties, Dr. Osman decided to open a new practice location.
Minimally invasive vs. open TLIF spine surgery
A study presented at the Society for Minimally Invasive Spine Surgery Global Forum in 2014 compared minimally invasive and open transforaminal lumbar interbody fusion at two levels. Minimally invasive and open procedures had comparable operative time, and no postoperative drainage. The minimally invasive patients underwent a longer fluoroscopic time and less intraoperative blood loss. The MIS patients also needed less morphine.
CMS broadens participation in APMs for orthopedic, cardiac care
CMS is allowing more physicians to participate in Medicare's advanced alternative payment models for hip procedures, femur procedures, bypass surgery and heart attack care. CMS requires hospitals in the affected geographic areas to participate in the new models. However, participation is voluntary for physicians. Starting July 1, 2017, the models will operate for five years.
North America leads global non-fusion spinal devices market
The global non-fusion spinal devices market is expected to grow between 2015 and 2025. An aging population, increasing number of obesity cases and rising demand for minimally invasive procedures will spur market growth. North America accounts for the largest market share, due to about 50 percent of the U.S. population over 40 years of age experiencing degenerative disc disease.
10th patient enrolled in INSPIRE study
Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient into its INSPIRE study, which tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury. Charlotte, N.C.-based Carolinas Medical Center enrolled the patient. This patient marks the 10th patient enrolled and in follow up. The INSPIRE is designed to enroll 20 patients.
Stavros Vizirgianakis to lead Misonix as new president, CEO
Farmingdale, N.Y.-based Misonix named Stavros G. Vizirgianakis the new president and CEO, effective immediately. Since Sept. 2, 2016, Mr. Vizirgianakis has been serving as Misonix's interim CEO. He has served as a Misonix board member since May 2013.